Please login to the form below

Not currently logged in

Pharmaceutical Market Europe - February 2013

This issue PME talks to …

Steven Bates

The BioIndustry Association CEO talks about the state of UK biotech, its shared ecosystem with the country's pharmaceutical industry and the funding challenges biotech faces 

And we take a look at …

Orphan diseases

Orphan diseases represent one of the most exciting and emotive areas in modern medicine and need a communications strategy that covers a spectrum of issues, say Dr Jonathan Morton and Dr Richard White of OxfordPharmagenesis

South Korea: the ascendance of biobetters

Global pharma companies need to take the capabilities and experience of South Korean firms into consideration when developing their competitive strategies

Masterclass: channel strategy

Channel strategy could be a significant stone unturned in the battle to win customers and patients, says David Watson of a MSI Consultancy

Innovation: what to look out for in 2013

Context-based services and social media are among the major technology trends that pharma will need to embrace in the year ahead

Pipeline: promising treatments for melanoma

The BREAK-2 phase II trial showed that dabrafenib 150mg twice daily had rapid onset of action, high response rates and prolonged progression-free survival 

View PME February 2013 online

Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.

PME is also available to download as an app for iPhone and iPad

Please note: Some older digital editions may no longer be accessible while we transition to a new digital edition system and app -

COVID-19 Updates and Daily News

Featured jobs


Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...